<<

Heart 2001;86:489–490 489

FEATURED CLINICAL CASE : first published as 10.1136/heart.86.5.489 on 1 November 2001. Downloaded from

Torsade de pointes as a rare manifestation of acute enteroviral

C BadorV, A M Zeiher, S H Hohnloser

Abstract ECG showed anterior inversion (fig A patient with and docu- 1A) and both creatine kinase (258 U/l) and mented torsade de pointes ventricular creatine kinase MB fraction (36 U/l) were tachycardia is presented in whom acute increased, acute was ini- coxsackievirus B2 myocarditis was identi- tially suspected. However, on angiography the fied as the most likely underlying cardiac coronary were seen to be free of condition. This case shows that torsade de significant stenoses. Importantly, left ventricu- pointes may occur as a rare manifestation lar function was significantly impaired (ejec- of viral myocarditis. Serial serological tion fraction 25–30%) with an enlarged left tests and endomyocardial biopsies may be ventricular diastolic diameter (65 mm) and an helpful in establishing a diagnosis in such increased left ventricular end diastolic pressure patients. (20 mm Hg), consistent with a dilated cardio- (Heart 2001;86:489–490) myopathy phenotype. Subsequently, the patient developed non- Keywords: torsade de pointes; ; viral myocarditis sustained, torsade de pointes ventricular tachy- cardia in the setting of a prolonged QT Torsade de pointes is a polymorphous ven- duration (fig 1B). Serum electrolytes were tricular tachycardia in which the QRS com- within normal limits and the patient was not Division of , plexes oscillate around the isoelectrical line. It receiving any QT prolonging drugs. Most Department of occurs in the presence of a hereditary or likely, the previous episode of ventricular fibril- Internal Medicine IV, acquired long QT syndrome, the latter being lation had been caused by secondary degenera- University of most commonly induced by drugs or toxins.12 tion of a similar torsade de pointes. Frankfurt, http://heart.bmj.com/ However, only sparse reports exist indicating On the basis of the medical history acute Theodor-Stern-Kai 7, myocarditis was suspected. Therefore, a first 60590 Frankfurt/Main, an association of acute myocarditis with this Germany form of .34 serum sample was drawn for determination of C BadorV viral titres and endomyocardial biopsies were A M Zeiher taken from the right side of the interventricular S H Hohnloser Case report septum. A 39 year old female patient was successfully Routine haematoxylin and eosin staining Correspondence to: resuscitated from out of hospital cardiac arrest showed an increased interstitial area between Dr BadorV caused by ventricular fibrillation. Her medical [email protected] the cardiomyocytes with oedema, fibrosis, and on October 1, 2021 by guest. Protected copyright. history was unremarkable apart from a flu like enhanced cellularity (fig 2A). Immunostaining Accepted 2 July 2001 illness two weeks previously. Since the 12 lead for the common leucocyte antigen (CD45) identified multiple inflammatory infiltrates in A the myocardium (fig 2B). Since enteroviruses I V1 are common aetiological agents in viral myo- , immunostaining was performed using II V 2 an antibody against the enterovirus group spe- cific capsid antigen VP-1 as described.5 An area V III 3 encompassing several virally infected cardio- myocytes with a preferential sarcolemmal VP-1 aVR V4 signal was detected (fig 2C). The same sarcolemmal staining pattern for VP-1 was aVL V5 observed in mouse experimentally infected with coxsackievirus B3 (fig 2D). Con- aVF V6 trol stains with an isotype control mouse IgG as B primary antibody did not produce any signal (data not shown). A second serum sample taken from the patient 10 days later showed a fourfold increase (from 1:40 to 1:160) of the neutralising antibody titre against coxsackievirus B2. Titres Figure 1 (A) Initial 12 lead ECG (25 mm/s) with anterior T wave inversions. (B) Torsade de pointes like ventricular tachycardia. The sinus beat following spontaneous against all other coxsackievirus serotypes tested termination of the tachycardia shows a prolonged QT duration. (A9, A21, B1, B3–6), parvovirus B19, herpes

www.heartjnl.com 490 BadorV, Zeiher, Hohnloser Heart: first published as 10.1136/heart.86.5.489 on 1 November 2001. Downloaded from

Figure 2 Endomyocardial biopsy results. (A) Haematoxylin and eosin staining, ×200. (B) CD45 immunostaining with horseradish peroxidase signal detection, ×200. Note the abundance and foci of inflammatory cells. (C) Immunostaining for the enteroviral VP-1 antigen with horseradish peroxidase signal detection, ×200. Note the strong sarcolemmal staining pattern in a group of cardiomyocytes. (D) VP-1 immunofluorescence staining of a mouse heart experimentally infected with coxsackievirus B3, ×400. The virally infected cells show a strong signal similar to the pattern described in C. simplex virus, cytomegalovirus, and adeno- In summary, torsade de pointes ventricular virus remained constant. tachycardia can occur as a rare but life threat- http://heart.bmj.com/ Taken together, these findings identified ening manifestation of acute viral myocarditis. acute coxsackievirus B2 myocarditis as the Viral myocarditis may be considered as a most likely cause of the torsade de pontes ven- potential cause in aetiologically unclear cases tricular tachycardia in our patient. of torsade de pointes. Serological tests as well as endomyocardial biopsies may be helpful in Discussion establishing a diagnosis in these patients. Our patient illustrates three clinical presenta- tions of viral myocarditis: acute myocardial inf- on October 1, 2021 by guest. Protected copyright. Supported by a grant from the Deutsche Forschungsgemein- arction, recent onset dilated , schaft to CB (Ba 1668/3-1). and sudden death.6 In principal, any arrhyth- mia may complicate viral myocarditis where the lytic nature of the viral or the 1 Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variable. Arch Mal Coeur 1966;59:263–72. resulting inflammatory reaction may cause 2 El-Sherif N, Turitto G. The long QT syndrome and torsade inhomogeneous repolarisation and an unstable de pointes. PACE 1999;22:91–110. 3 Sareli P, Schamroth CL, Passias J, et al. Torsade de pointes membrane potential in aVected cardiomyo- due to coxsackie B3 myocarditis. Clin Cardiol 1987;10:361– cytes. These abnormalities may facilitate ven- 2. 4 Fiddler GI, Campbell RWF, Pottage A, et al. Varicella myo- tricular tachyarrhythmias through re-entrant carditis presenting with unsual ventricular . Br mechanisms or enhanced autonomy, respec- Heart J 1977;39:1150–3. tively. We previously reported a mechanism 5 Li Y, Bourlet T, Andreoletti L, et al. Enteroviral capsid pro- tein VP1 is present in myocardial tissues from some that may underlie these eVects: cleavage of the patients with myocarditis or . Circu- cytoskeletal protein dystrophin by the coxsack- lation 2000;101:231–4. 6 Karjalainen J, Heikkila J. Incidence of the three presenta- ieviral protease 2A with subsequent disruption tions of acute myocarditis in young men in military service: of the membrane-anchoring dystrophin glyco- a 20-year experience. Eur Heart J 1999;20:1120–5. 7 BadorV C, Lee GH, Lamphear BJ, et al. Enteroviral protease protein complex and enhanced sarcolemmal 2A cleaves dystrophin: evidence of cytoskeletal disruption 7 permeability in vitro and in vivo. in an acquired cardiomyopathy. Nat Med 1999;5:320–6.

www.heartjnl.com